Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.220
+0.025 (2.09%)
Apr 2, 2025, 4:00 PM EDT - Market closed

LIXT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
35581639
Upgrade
Market Cap Growth
-13.63%-13.63%-37.62%-48.20%-58.30%-13.83%
Upgrade
Enterprise Value
26451442
Upgrade
Last Close Price
1.202.032.355.0911.9031.70
Upgrade
PB Ratio
3.835.521.321.643.427.83
Upgrade
P/TBV Ratio
--10.685.0912.6825.95
Upgrade
Quick Ratio
3.263.2613.3913.5315.9223.41
Upgrade
Current Ratio
3.603.6013.7314.0516.8124.15
Upgrade
Return on Equity (ROE)
-148.73%-148.73%-111.07%-126.81%-137.28%-87.69%
Upgrade
Return on Assets (ROA)
-81.88%-81.88%-64.47%-74.05%-81.39%-51.68%
Upgrade
Return on Capital (ROIC)
-92.62%-92.62%-69.46%-79.25%-85.70%-54.84%
Upgrade
Earnings Yield
-113.22%-78.55%-96.24%-74.50%-41.13%-8.32%
Upgrade
Buyback Yield / Dilution
-17.41%-17.41%-21.10%-17.41%-19.48%-0.92%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q